Apimeds Pharmaceuticals US Inc
APUS2.020USD
+0.190+10.38%
종가 09/19, 16:00（ET）시세는 15분 지연됩니다
25.40M시가총액
손실P/E TTM
자세한 내용은 Apimeds Pharmaceuticals US Inc 회사
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
회사 정보
종목 코드 APUS
회사 이름Apimeds Pharmaceuticals US Inc
상장일May 09, 2025
CEOMr. Erik C. Emerson
직원 수2
유형Ordinary Share
회계 연도 종료May 09
주소100 Matawan Road
도시MATAWAN
증권 거래소NYSE American Consolidated
국가United States of America
우편 번호07747
전화18482015010
웹사이트https://www.apimedsus.com/
종목 코드 APUS
상장일May 09, 2025
CEOMr. Erik C. Emerson
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Erik C. Emerson
Mr. Erik C. Emerson
Chief Executive Officer, Director
Chief Executive Officer, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
643.88K
+4.63%
Dr. Christopher Kim, M.D.
Dr. Christopher Kim, M.D.
Chairman of the Board, Chief Medical Officer
Chairman of the Board, Chief Medical Officer
277.50K
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Dr. Hankil Yoon, Ph.D.
Dr. Hankil Yoon, Ph.D.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Erik C. Emerson
Mr. Erik C. Emerson
Chief Executive Officer, Director
Chief Executive Officer, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
643.88K
+4.63%
Dr. Christopher Kim, M.D.
Dr. Christopher Kim, M.D.
Chairman of the Board, Chief Medical Officer
Chairman of the Board, Chief Medical Officer
277.50K
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Wed, Sep 3
마지막 업데이트: Wed, Sep 3
주주
주주 유형
주주
주주
비율
Apimeds, Inc.
34.89%
Inscobee, Inc.
16.13%
Dominus IB, Inc
6.36%
Emerson (Erik C)
5.96%
Koo (Jakap)
5.12%
기타
31.53%
주주
주주
비율
Apimeds, Inc.
34.89%
Inscobee, Inc.
16.13%
Dominus IB, Inc
6.36%
Emerson (Erik C)
5.96%
Koo (Jakap)
5.12%
기타
31.53%
주주 유형
주주
비율
Corporation
62.15%
Individual Investor
13.29%
Hedge Fund
0.13%
Research Firm
0.10%
Investment Advisor
0.06%
Investment Advisor/Hedge Fund
0.02%
기타
24.25%
기관 주식 보유
마지막 업데이트: Wed, Jul 2
마지막 업데이트: Wed, Jul 2
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
7
9.49M
81.96%
+7.39M
2025Q2
7
9.49M
81.96%
+7.39M
2025Q1
2
2.10M
18.15%
+2.10M
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Apimeds, Inc.
4.39M
37.9%
+4.39M
--
May 12, 2025
Inscobee, Inc.
2.03M
17.52%
+544.04K
+36.65%
May 12, 2025
Dominus IB, Inc
800.00K
6.91%
+800.00K
--
May 09, 2025
Emerson (Erik C)
750.00K
6.48%
+750.00K
--
May 16, 2025
Koo (Jakap)
643.88K
5.56%
+28.50K
+4.63%
May 12, 2025
Seed 1 ho
600.00K
5.18%
+600.00K
--
May 09, 2025
Kim (Christopher)
277.50K
2.4%
+277.50K
--
May 16, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
